Porvair Filtration Group has signed a long-term agreement with Parker Aerospace to provide filtration systems for the company?s on-board aircraft fuel tank inerting systems.
Porvair Filtration Group has signed a long-term agreement with Parker Aerospace to provide filtration systems for the company’s on-board aircraft fuel tank inerting systems.
The lightweight system removes oxygen from a source of engine bleed air with an air separation module (ASM) before delivering nitrogen-enriched air into the aircraft fuel tanks. Porvair’s filtration systems will protect these ASM modules that are particularly sensitive to contamination thus increasing safety and reducing the risk of fuel tank flammability. The systems are used in passenger aircraft such as those manufactured by Boeing and Airbus.
Tom Liddell, managing director of Porvair Filtration Group stated, “This agreement is the successful result of many years of investment in the development of the inerting solution. We are delighted to be working with Parker on existing and future projects.”
Scott Pearson, business unit manager of fuel and inerting at Parker Aerospace Fluid Systems Division added, “Our alignment with Porvair as supplier of this critical filtration equipment is a testament to their technical capability and delivery performance to date. Their products ensure our inerting systems remain at the forefront of the technology.”
For more information visit www.porvairfiltration.com or e-mail Porvair.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Profiling Volatile Organic Compounds in Whisky with GC×GC–MS
November 1st 2024Researchers from Austria, Greece, and Italy conducted a study to analyze volatile organic compounds (VOCs) present in Irish and Scotch whiskys using solid-phase microextraction (SPME) Arrow with comprehensive two-dimensional gas chromatography coupled to mass spectrometry (GC×GC–MS) to examine the organoleptic characteristics that influence the taste of spirits.
GC–TOF-MS Finds 250 Volatile Compounds in E-Cigarette Liquids
November 1st 2024A study has used gas chromatography coupled to a time-of-flight mass spectrometer to build an electron ionization mass spectra database of more than 250 chemicals classified as either volatile or semi-volatile compounds. An additional, confirmatory layer of liquid chromatography–mass spectrometry analysis was subsequently performed.